相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination of Amino Acid Substitutions Leading to CTX-M-15-Mediated Resistance to the Ceftazidime-Avibactam Combination
Fabrice Compain et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
Jesus Rodriguez-Bano et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Past and Present Perspectives on β-Lactamases
Karen Bush
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Selection of mutants with resistance or diminished susceptibility to ceftazidime/avibactam from ESBL-and AmpC-producing Enterobacteriaceae
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Impaired Inhibition by Avibactam and Resistance to the Ceftazidime-Avibactam Combination Due to the D179Y Substitution in the KPC-2 β-Lactamase
Fabrice Compain et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Inhibition by Avibactam and Clavulanate of the β-Lactamases KPC-2 and CTX-M15 Harboring the Substitution N132G in the Conserved SDN Motif
Clement Ourghanlian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC
Sushmita D. Lahiri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Avibactam and Class C β-Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for Resistance
S. D. Lahiri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenems
Krisztina M. Papp-Wallace et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-Lactamases
Sushmita D. Lahiri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Contribution of asparagine 346 residue to the carbapenemase activity of CMY-2 β-lactamase
Sandrine Dahyot et al.
FEMS MICROBIOLOGY LETTERS (2013)
Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor
David E. Ehmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa
Jose-Manuel Rodriguez-Martinez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Contribution of extended-spectrum AmpC (ESAC) β-lactamases to carbapenem resistance in Escherichia coli
Hedi Mammeri et al.
FEMS MICROBIOLOGY LETTERS (2008)
Promoter sequences necessary for high-level expression of the plasmid-associated ampC β-lactamase gene blaMIR-1
MD Reisbig et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Plasmid-determined AmpC-type beta-lactamases
A Philippon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
分享论文
